Napo Pharmaceuticals Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.3M
Doctors Paid
1,946
Transactions
8,934
2024 Total
$704,624
Payment Breakdown by Category
Research$2.3M (70.3%)
Consulting$326,577 (9.8%)
Food & Beverage$160,044 (4.8%)
Travel$39,967 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 346 | 70.3% |
| Consulting Fee | $326,577 | 102 | 9.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $264,932 | 1,763 | 8.0% |
| Food and Beverage | $160,044 | 6,539 | 4.8% |
| Honoraria | $131,675 | 80 | 4.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $62,174 | 22 | 1.9% |
| Travel and Lodging | $39,967 | 82 | 1.2% |
Payments by Type
Research
$2.3M
346 transactions
General
$985,369
8,588 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Phase 3 Multicenter, Randomized, Double Blind Placebo-Controlled Trial Evaluating Crofelemer for the Prophylaxis of Diarrhea in Adult Patients with Solid Tumors Receiving Targeted-Cancer Therapies with or without Standar Chemotherapy | $2.0M | 0 | 259 |
| ON TARGET: A Phase 3 multicenter, randomized, double-blind placebo-controlled trial evaluating crofelemer for the prophylaxis of diarrhea in adult patients with solid tumors receiving targeted-cancer therapies with or without standard chemotherapy regimens | $178,994 | 0 | 50 |
| One Patient IND | $83,298 | 0 | 10 |
| A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living with HIV/AIDS (PLWHA) with Non-Infectious Diarrhea | $57,412 | 0 | 22 |
| Yield of Diagnostic Tests and Management of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients: A Pilot Study | $22,061 | 0 | 3 |
| A randomized, double-blind, placebo-controlled, parallel group, multicenter study is designed to evaluate the efficacy and safety of orally administered crofelemer in patients with functional diarrhea. | $22,061 | 0 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Carlos Choucino, Md, MD | Infectious Disease | Lake Charles, LA | $6,735 | $0 |
| Mr. William Flores, P.a, P.A | Physician Assistant | Beverly Hills, CA | $6,494 | $0 |
| Dr. Jihad Slim, Md, MD | Infectious Disease | Newark, NJ | $6,024 | $0 |
| Dr. Shawn Hassler, M.d, M.D | Infectious Disease | San Francisco, CA | $5,458 | $0 |
| Unknown Provider | — | — | $5,404 | $0 |
| Mark Higgins, Md, MD | Internal Medicine | San Francisco, CA | $5,393 | $0 |
| Dr. Claudio Tuda, M.d, M.D | Infectious Disease | Miami Beach, FL | $4,380 | $0 |
| Dr. Hetal Karsan, Md, MD | Gastroenterology | Atlanta, GA | $4,303 | $0 |
| Sheetal Sharma, Md, MD | Internal Medicine | Fort Lauderdale, FL | $4,258 | $0 |
| Dr. Joseph Chan, M.d, M.D | Infectious Disease | Miami Beach, FL | $4,035 | $0 |
| Ms. Edith Biggers, Md, MD | General Practice | Atlanta, GA | $3,988 | $0 |
| Margaret Gorensek, Md, MD | Infectious Disease | Fort Lauderdale, FL | $3,915 | $0 |
| Unknown Provider | — | — | $3,676 | $0 |
| Mr. John Phoenix, Aprn, APRN | Family | Las Vegas, NV | $3,650 | $0 |
| Unknown Provider | — | — | $3,393 | $0 |
| Jeremiah Robinson, P.a.-C, P.A.-C | Medical | Atlanta, GA | $3,168 | $0 |
| Douglas Wolf, Md, MD | Gastroenterology | Atlanta, GA | $3,137 | $0 |
| David Rubin | Gastroenterology | Chicago, IL | $3,110 | $0 |
| Christine Frissora-Rodeo, Md, MD | Internal Medicine | New York, NY | $2,137 | $0 |
| Ms. Hazel Jones-Parker, Crnp, CRNP | Family | Baltimore, MD | $2,102 | $0 |
| Michael Hymbaugh, M.d, M.D | Internal Medicine | Baton Rouge, LA | $2,074 | $0 |
| Maurice Brownlee, Aprn, APRN | Adult Health | Chicago, IL | $2,036 | $0 |
| Dr. Christopher Duggan, Md, Mph, MD, MPH | Physician Nutrition Specialist | Boston, MA | $1,679 | $0 |
| Calvin Pan, M.d, M.D | Internal Medicine | Flushing, NY | $1,619 | $0 |
| Lin Chang, Md, MD | Gastroenterology | Los Angeles, CA | $1,603 | $0 |
About Napo Pharmaceuticals Inc
Napo Pharmaceuticals Inc has made $3.3M in payments to 1,946 healthcare providers, recorded across 8,934 transactions in the CMS Open Payments database. In 2024, the company paid $704,624. The top product by payment volume is Mytesi ($1.1M).
Payments were distributed across 79 medical specialties. The top specialty by payment amount is Infectious Disease ($177,692 to 327 doctors).
Payment categories include: Food & Beverage ($160,044), Consulting ($326,577), Research ($2.3M), Travel & Lodging ($39,967).
Napo Pharmaceuticals Inc is associated with 1 products in the CMS Open Payments database.